Task: Answer the multiple choice question.
Question: Which drug exhibits a -51.148% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] C#CCOC(=O)CCCNc1ccc([N+](=O)[O-])cc1[N+](=O)[O-]
[b] C=CCc1ccccc1OCC(O)CNC(C)C.Cl
Answer: a. C#CCOC(=O)CCCNc1ccc([N+](=O)[O-])cc1[N+](=O)[O-]
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCOC(=O)CCCNc1ccc([N+](=O)[O-])cc1[N+](=O)[O-]
C#CCOC(=O)CCCNc1ccc([N+](=O)[O-])cc1[N+](=O)[O-]
prop-2-ynyl 4-(2,4-dinitroanilino)butanoate